<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000046126"><TermName>nolatrexed</TermName><TermPronunciation>(NOH-luh-TREK-sed)</TermPronunciation><TermDefinition><DefinitionText>A substance that is being studied in the treatment of liver cancer. It belongs to the family of drugs called thymidylate synthase inhibitors. Also called AG337 and Thymitaq.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000731399" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nolatrexed&quot;" language="en" id="_3"/><MediaLink ref="CDR0000731398" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;nolatrexed&quot;" language="es" id="_4"/><SpanishTermName>nolatrexed</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento del cáncer de hígado. Es un tipo de inhibidor de la timidilato de sintasa. También se llama AG337 y Thymitaq.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateLastModified>2005-05-19</DateLastModified></GlossaryTerm>
